Multimodality Treatment of Advanced Non-small Cell Lung Cancer: Where are we with the Evidence?

PURPOSE OF REVIEW: The majority of patients with non-small cell lung cancer (NSCLC) present with advanced disease and overall survival rates are poor. This article outlines the current and outstanding evidence for the use of multimodality treatment in this group of patients, including in combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Christopher M., Brunelli, Alessandro, Callister, Matthew E., Franks, Kevin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Thoracic Surgery (G. Rocco and M. Scarci, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805813/
https://www.ncbi.nlm.nih.gov/pubmed/29456881
http://dx.doi.org/10.1007/s40137-018-0202-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805813/
https://www.ncbi.nlm.nih.gov/pubmed/29456881
http://dx.doi.org/10.1007/s40137-018-0202-0

Ejemplares similares